MAG-LAB

Based in Austria, MAG-LAB is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Artificial Intelligence & Data. Brouky records 1 investor associated with the company.

MAG-LAB provides NMR spectroscopy services combined with custom stable-isotope labeling of proteins and ligands to map and characterize protein–ligand interactions at atomic resolution, supporting hit-to-lead and lead optimization in drug discovery. They supply labeled precursors and offer protein expression/labeling, fragment screening, binding-site mapping and solution-structure analysis including intrinsically disordered proteins.